Bmc Cancer

Bmc Cancer

癌症

  • 2区 中科院分区
  • Q2 JCR分区

期刊简介

《Bmc Cancer》是由BioMed Central出版社于2001年创办的英文国际期刊(ISSN: 1471-2407,E-ISSN: 1471-2407),该期刊长期致力于肿瘤学领域的创新研究,主要研究方向为医学-肿瘤学。作为SCIE收录期刊(JCR分区 Q2,中科院 2区),本刊采用OA开放获取模式(OA占比1%),以发表肿瘤学领域等方向的原创性研究为核心(研究类文章占比95.11%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在1227篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Bmc Cancer审稿周期约为 约6.8月 。该刊近年未被列入国际预警名单,年发文量约1227篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 1227 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
2区
ONCOLOGY 肿瘤学
3区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
2区
ONCOLOGY 肿瘤学
3区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q2 110 / 322

66%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q2 121 / 322

62.58%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:6 SJR:1.087 SNIP:0.944
学科类别 分区 排名 百分位
大类:Medicine 小类:Oncology Q2 127 / 404

68%

大类:Medicine 小类:Genetics Q2 131 / 347

62%

大类:Medicine 小类:Cancer Research Q2 105 / 230

54%

期刊发文

  • Vitamin D receptor prevents tumour development by regulating the Wnt/beta-catenin signalling pathway in human colorectal cancer

    Author: Yu, Jie; Sun, Qi; Hui, Yi; Xu, Jinping; Shi, Pancheng; Chen, Yu; Chen, Yunzhao

    Journal: BMC CANCER. 2023; Vol. 23, Issue 1, pp. -. DOI: 10.1186/s12885-023-10690-z

  • Effects of preoperative albumin-to-globulin ratio on overall survival and quality of life in esophageal cell squamous carcinoma patients: a prospective cohort study

    Author: Zhang, Juwei; Lin, Zheng; Zhou, Jinsong; Huang, Yue; Chen, Siting; Deng, Yuan; Qiu, Minglian; Chen, Yuanmei; Hu, Zhijian

    Journal: BMC CANCER. 2023; Vol. 23, Issue 1, pp. -. DOI: 10.1186/s12885-023-10809-2

  • Automated Breast Ultrasound (ABUS)-based radiomics nomogram: an individualized tool for predicting axillary lymph node tumor burden in patients with early breast cancer

    Author: Chen, Yu; Xie, Yongwei; Li, Bo; Shao, Hua; Na, Ziyue; Wang, Qiucheng; Jing, Hui

    Journal: BMC CANCER. 2023; Vol. 23, Issue 1, pp. -. DOI: 10.1186/s12885-023-10743-3

  • Chidamide enhances cytotoxicity of doxorubicin by promoting autophagy and apoptosis in breast cancer

    Author: Li, Jieqing

    Journal: BMC CANCER. 2023; Vol. 23, Issue 1, pp. -. DOI: 10.1186/s12885-023-10774-w

  • Prognostic significance of inflammatory and nutritional markers in perioperative period for patients with advanced gastric cancer

    Author: Zhang, Ruolan; Hu, Can; Zhang, Jiaqing; Zhang, Yanqiang; Yuan, Li; Yu, Pengcheng; Wang, Yi; Bao, Zhehan; Cao, Mengxuan; Ruan, Rongwei; Cheng, Xiangdong; Xu, Zhiyuan

    Journal: BMC CANCER. 2023; Vol. 23, Issue 1, pp. -. DOI: 10.1186/s12885-022-10479-6

  • Lymphovascular invasion represents a superior prognostic and predictive pathological factor of the duration of adjuvant chemotherapy for stage III colon cancer patients

    Author: Zhang, Linjie; Deng, Yuxiang; Liu, Songran; Zhang, Weili; Hong, Zhigang; Lu, Zhenhai; Pan, Zhizhong; Wu, Xiaojun; Peng, Jianhong

    Journal: BMC CANCER. 2023; Vol. 23, Issue 1, pp. -. DOI: 10.1186/s12885-022-10416-7

  • Clinical significance of histopathological features of paired recurrent gliomas: a cohort study from a single cancer center

    Author: Li, Cong; Xi, Shaoyan; Chen, Yingshen; Guo, Chengcheng; Zhang, Ji; Yang, Qunying; Wang, Jian; Sai, Ke; Zeng, Jing; Wang, Jing; Zhang, Zhiqiang; Ke, Chao; Chen, Zhongping

    Journal: BMC CANCER. 2023; Vol. 23, Issue 1, pp. -. DOI: 10.1186/s12885-022-10484-9

  • Clinical characteristics and prognostic factors affecting survival after radical radiotherapy for early and late post-treatment metastatic nasopharyngeal carcinoma

    Author: Jia, Guo-Dong; Sun, Xue-Song; Li, Xiao-Yun; Liu, Sai-Lan; Yang, Jin-Hao; Chen, Qiu-Yan; Yuan, Li; Mai, Hai-Qiang

    Journal: BMC CANCER. 2023; Vol. 23, Issue 1, pp. -. DOI: 10.1186/s12885-022-10494-7